Sexualidad para el hombre con cáncer

+ -Text Size

TEMAS

Referencias

American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Male Sexual Dysfunction: A couple's problem – 2003. Update Endocr Pract. 2003;9(No. 1).

American Cancer Society. Prostate Cancer Detailed Guide. Accessed at www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=36 on March 3, 2010.

American Urological Association. 2006 Annual Meeting Highlights: Erectile dysfunction. AUA News, 2006. Accessed at www.auanet.org/content/education-and-meetings/on-line-education/amhighlights/ed.pdf on March 5, 2010.

American Urological Association. Clinical Guidelines: Management of Erectile Dysfunction. Accessed at www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=ed on March 3, 2010.

American Urological Association. Guideline on the Pharmacologic Management of Premature Ejaculation. Accessed at www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=pme on March 3, 2010.

Benson JS, Abern MR, Levine LA. Penile shortening after radical prostatectomy and Peyronie's surgery. Curr Urol Rep. 2009;10(6):468-74.

Bissada NK, Yakout HH, Fahmy WE, et al. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol. 2003;169:500-502.

Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol. 2007;177(6):2223-6.

Choo R, Long J, Gray R, et al. Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function. Support Care Cancer. Published online: 09 June 2009.

Clifford D. Caring for sexuality in loss. In Wells, D. (Ed.) Caring for Sexuality in Health and Illness. Philadelphia, PA; Churchill Livingstone. 2000:85-105.

Dohle GR. Male infertility in cancer patients: Review of the literature. Int J Urol. 2010 Jan:1-5

Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61

Grover SA, Lowensteyn I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006;3;166:213-219.

Hellstrom WJ, Montague DK, Moncada I, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010;7(1 Pt 2):501-23.

Katz, A. Man Cancer Sex. Pittsburgh: Hygeia Media, 2010.

Katz A. The Sounds of Silence: sexuality information for cancer patients. J Clin Onc. 2005;23:238-241.

Kendirci M, Hellstrom WJ. Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer. 2004;3:87-92.

Knight D. Health Care Screening for Men Who Have Sex with Men. Am Fam Physician. 2004;69:2149-2156.

Lee J, Hersey K, Lee CT, Fleshner N. Climacturia following radical prostatectomy: prevalence and risk factors. J Urol. 2006;176(6 Pt 1):2562-5

Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb

Mort Wkly Rep. 2007;56(RR-2):1-24.

Martins FE, Rodrigues RN, Lopes TM. Organ-preserving surgery for penile carcinoma. Adv Urol. 2008. Accessed at www.ncbi.nlm.nih.gov/pmc/articles/PMC2581733/?tool=pubmed on March 5, 2010.

Meistrich ML, Vassilopoulou-Sellin R, Lipshultz LI. Gonadal Dysfunction. In DeVita VT, Hellman S, Rosenberg SA (Eds). Cancer: Principles and Practice of Oncology, 7th ed. 2005: Lippincott Williams & Wilkins, New York. 2560-2574.

Mulhall J, Land S, Parker M, et al. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. The Journal of Sexual Medicine. 2005;2:540-542.

National Cancer Institute. Sexuality and Reproductive Issues (PDQ®). Accessed at www.cancer.gov/cancertopics/pdq/supportivecare/sexuality/HealthProfessional on March 3, 2010.

Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96:1358-1367.

Riscoll L. Bigger, harder, better: natural sex enhancers or Viagra-era snake oil? Contemporary Sexuality. Accessed at http://aasect.org/NEWS/may2003.asp on January 2005.

US Food and Drug Administration. International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement. Recall -- Firm Press Release, May 29, 2008. Accessed at www.fda.gov/oc/po/firmrecalls/internationalpharma05_08.html on November 24, 2008.

US Food and Drug Administration. Palo Alto Labs Issues a Voluntary Nationwide Recall of Aspire36 and Aspire Lite, two Products Marketed as Dietary Supplements. Recall -- Firm Press Release, February 20, 2008. Accessed at www.fda.gov/oc/po/firmrecalls/paloalto02_08.html on November 24, 2008.

Wespes E, Amar E, Eardley I, et al. Guidelines on Male Sexual Dysfunction: Erectile dysfunction and premature ejaculation. European Association of Urology 2009. Update March 2009. Accessed at www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/Male_Sexual_Dysf.pdf on March 11, 2010.


Fecha de última actualización: 09/02/2010
Fecha de último cambio o revisión: 09/02/2010